A Tale of Two Diseases: Decoding Aortic Stenosis and Cardiac Amyloidosis
Authors:
- Ioannis GialamasIGIoannis Gialamas
- George E. ZakynthinosGeorge E. Zakynthinos
- George DimeasGDGeorge Dimeas
- Panteleimon PantelidisPanteleimon Pantelidis
- Elias GialafosEGElias Gialafos
- Styliani BriliSBStyliani Brili
- Athina GoliopoulouAGAthina Goliopoulou
- Ourania KatsarouOKOurania Katsarou
- Elsi TryfouETElsi Tryfou
- Konstantinos KalogerasKKKonstantinos Kalogeras
- Gerasimos SiasosGSGerasimos Siasos
- Evangelos OikonomouEvangelos Oikonomou
Open Access
- 12 April 2025
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2652
Abstract
Background/Objectives: Transthyretin cardiac amyloidosis (ATTR-CA) is an infiltrative cardiomyopathy caused by transthyretin (TTR) amyloid deposition in the myocardium, increasingly recognized in patients with aortic stenosis (AS). This study aims to investigate the diagnostic challenges and therapeutic strategies for patients with both conditions, focusing on shared pathophysiological mechanisms and key diagnostic indicators. Methods: A multimodal diagnostic approach was applied, utilizing cardiac magnetic resonance (CMR) and bone scintigraphy with technetium-99m-labeled tracers to assess AS patients with suspected ATTR-CA. Clinical signs, such as disproportionate heart failure symptoms, conduction abnormalities, and low-flow, low-gradient AS, were evaluated. Electrocardiographic findings, including low-voltage QRS complexes and pseudo-infarction patterns, were also assessed. Treatment options, including transcatheter aortic valve replacement (TAVR) and emerging pharmacotherapies for ATTR-CA, were analyzed. Results: The study found that ATTR-CA is increasingly prevalent in AS patients, with shared mechanisms like oxidative stress and amyloid-induced tissue remodeling. Key diagnostic signs include disproportionate heart failure symptoms, conduction abnormalities, and specific electrocardiographic patterns. TAVR was effective in both isolated AS and AS with ATTR-CA, although patients with both conditions had a higher risk of heart failure hospitalization and persistent symptoms. Emerging pharmacotherapies, such as TTR stabilizers and gene-silencing agents, showed promise in slowing disease progression. Conclusions: A multimodal diagnostic approach is essential for the early detection of ATTR-CA in AS patients. Combining TAVR with emerging pharmacotherapies may improve long-term outcomes for this high-risk group, enhancing patient care in those with both conditions.Keywords
This publication has 108 references indexed in Scilit:
- Multi-modality artificial intelligence-based transthyretin amyloid cardiomyopathy detection in patients with severe aortic stenosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Troponin T Hold Diagnostic Value in Cardiac AmyloidosisEuropean Journal of Heart Failure, 2023
- Atrial amyloidosis: mechanisms and clinical manifestationsEuropean Journal of Heart Failure, 2022
- Transcatheter Aortic Valve Replacement in Aortic Stenosis and Cardiac Amyloidosis: A Systematic Review and Meta-AnalysisESC Heart Failure, 2022
- Double trouble: severe aortic stenosis and cardiac amyloidosisWiener klinische Wochenschrift, 2020
- Aortic stenosis, transcatheter aortic valve replacement and transthyretin cardiac amyloidosis: are we progressively unraveling the tangle?European Journal of Heart Failure, 2020
- Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosisEuropean Journal of Heart Failure, 2020
- Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart diseaseThe International Journal of Cardiovascular Imaging, 2020
- Light-Chain and Transthyretin Cardiac Amyloidosis in Severe Aortic Stenosis: Prevalence, Screening Possibilities, and OutcomeEuropean Journal of Heart Failure, 2020
- Utility of the inversion scout sequence (TI scout) in diagnosing myocardial amyloid infiltrationThe International Journal of Cardiovascular Imaging, 2012